Cervical Cancer

Critical race theory originated in a legal framework but has implications in the conduct of cancer research, according to Mya L. Roberson, PhD.

February is National Cancer Prevention Month.

Cemiplimab extended OS compared with single-agent chemotherapy for women with recurrent cervical cancer, according to randomized phase 3 study results published in The New England Journal of Medicine.

Balstilimab plus zalifrelimab demonstrated promising and durable activity among women with recurrent and/or metastatic cervical cancer who relapsed after platinum-based therapy, according to a phase 2 study in Journal of Clinical Oncology.

Recent evidence indicates that mortality due to cervical cancer may have decreased as much as 50% among younger populations vaccinated against HPV. A video discussion of the data was the top story in hematology/oncology last week.

In the final installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about which adults may derive the most benefit from catch-up HPV vaccination.

The proportion of women in the U.S. who were not up to date on recommended cervical cancer screening significantly increased from 2005 to 2019, according to findings published in JAMA Network Open.

In the third installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about how clinicians can help overcome HPV vaccine hesitancy.

In the second installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the impact of HPV vaccination on the global burden of cervical cancer.

In the first installment of a four-video series timed to Cervical Cancer Awareness Month, Maurie Markman, MD, spoke with Healio about the importance of HPV vaccination.